BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 20392806)

  • 1. Targeting intermediary metabolism in the hypothalamus as a mechanism to regulate appetite.
    Lopaschuk GD; Ussher JR; Jaswal JS
    Pharmacol Rev; 2010 Jun; 62(2):237-64. PubMed ID: 20392806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of malonyl-CoA in heart disease and the hypothalamic control of obesity.
    Folmes CD; Lopaschuk GD
    Cardiovasc Res; 2007 Jan; 73(2):278-87. PubMed ID: 17126822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of food intake and energy expenditure by hypothalamic malonyl-CoA.
    Lane MD; Wolfgang M; Cha SH; Dai Y
    Int J Obes (Lond); 2008 Sep; 32 Suppl 4():S49-54. PubMed ID: 18719599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of malonyl-CoA in the hypothalamic control of food intake and energy expenditure.
    Lane MD; Hu Z; Cha SH; Dai Y; Wolfgang M; Sidhaye A
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):1063-7. PubMed ID: 16246046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of lipids in the control of food intake.
    Fantino M
    Curr Opin Clin Nutr Metab Care; 2011 Mar; 14(2):138-44. PubMed ID: 21252653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of glucose and fructose on food intake via malonyl-CoA signaling in the brain.
    Lane MD; Cha SH
    Biochem Biophys Res Commun; 2009 Apr; 382(1):1-5. PubMed ID: 19265677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effect of prolonged food restriction and fasting on hypothalamic malonyl-CoA concentration and expression of orexigenic and anorexigenic neuropeptides genes in rats.
    Sucajtys-Szulc E; Turyn J; Goyke E; Korczynska J; Stelmanska E; Slominska E; Smolenski RT; Rutkowski B; Swierczynski J
    Neuropeptides; 2010 Feb; 44(1):17-23. PubMed ID: 20004973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypothalamic malonyl-CoA as a mediator of feeding behavior.
    Hu Z; Cha SH; Chohnan S; Lane MD
    Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12624-9. PubMed ID: 14532332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central lactate metabolism suppresses food intake via the hypothalamic AMP kinase/malonyl-CoA signaling pathway.
    Cha SH; Lane MD
    Biochem Biophys Res Commun; 2009 Aug; 386(1):212-6. PubMed ID: 19523445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of hypothalamic malonyl-CoA in energy homeostasis.
    Wolfgang MJ; Lane MD
    J Biol Chem; 2006 Dec; 281(49):37265-9. PubMed ID: 17018521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypothalamic malonyl-CoA and the control of food intake.
    Gao S; Moran TH; Lopaschuk GD; Butler AA
    Physiol Behav; 2013 Oct; 122():17-24. PubMed ID: 23988346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of hypothalamic AMP-kinase in food intake regulation.
    Minokoshi Y; Shiuchi T; Lee S; Suzuki A; Okamoto S
    Nutrition; 2008 Sep; 24(9):786-90. PubMed ID: 18725075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malonyl-CoA mediates leptin hypothalamic control of feeding independent of inhibition of CPT-1a.
    Gao S; Keung W; Serra D; Wang W; Carrasco P; Casals N; Hegardt FG; Moran TH; Lopaschuk GD
    Am J Physiol Regul Integr Comp Physiol; 2011 Jul; 301(1):R209-17. PubMed ID: 21508288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuro-hormonal control of food intake: basic mechanisms and clinical implications.
    Konturek PC; Konturek JW; Cześnikiewicz-Guzik M; Brzozowski T; Sito E; Konturek SJ
    J Physiol Pharmacol; 2005 Dec; 56 Suppl 6():5-25. PubMed ID: 16340035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of central ghrelin on fatty acid metabolism in hypothalamic ventral medial and arcuate nuclei.
    Gao S; Casals N; Keung W; Moran TH; Lopaschuk GD
    Physiol Behav; 2013 Jun; 118():165-70. PubMed ID: 23680429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of hypothalamic fatty acid synthase triggers rapid activation of fatty acid oxidation in skeletal muscle.
    Cha SH; Hu Z; Chohnan S; Lane MD
    Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14557-62. PubMed ID: 16203972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypothalamic malonyl-CoA and CPT1c in the treatment of obesity.
    Wolfgang MJ; Lane MD
    FEBS J; 2011 Feb; 278(4):552-8. PubMed ID: 21199367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity: the role of hypothalamic AMP-activated protein kinase in body weight regulation.
    Lee WJ; Koh EH; Won JC; Kim MS; Park JY; Lee KU
    Int J Biochem Cell Biol; 2005 Nov; 37(11):2254-9. PubMed ID: 16085448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Important roles of brain-specific carnitine palmitoyltransferase and ceramide metabolism in leptin hypothalamic control of feeding.
    Gao S; Zhu G; Gao X; Wu D; Carrasco P; Casals N; Hegardt FG; Moran TH; Lopaschuk GD
    Proc Natl Acad Sci U S A; 2011 Jun; 108(23):9691-6. PubMed ID: 21593415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of hepatic fatty acid oxidation by 5'-AMP-activated protein kinase involves a malonyl-CoA-dependent and a malonyl-CoA-independent mechanism.
    Velasco G; Geelen MJ; Guzmán M
    Arch Biochem Biophys; 1997 Jan; 337(2):169-75. PubMed ID: 9016810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.